Leading scientific strategy, computational biology, and data-driven decision-making for a cardiometabolic drug discovery platform. Building the analytical and SaaS foundation for target discovery and advancing the pipeline from hypothesis through IND-enabling studies.
Creating hypotheses for leading assets in HFpEF indications; developing end-to-end bioinformatics platform for cardiovascular drug discovery.
Bioscope AI (SAB): Advising on AI-driven precision medicine platform integrating EHR, genomics, and phenotypic data for translational insights and clinical decision support.
Melior Discovery (ML Advisor): Leading ML strategy for modeling experimental variability in preclinical disease models to improve reproducibility and statistical power.
Led bioinformatics strategy and platform development for target discovery and translational research in metabolic and neurological diseases.
Led computational modeling and bioinformatics initiatives within an NIH SPARC-funded program studying cardiac neural circuits.
Developed COMPACT, a novel computational framework for comparative gene expression analysis; published in peer-reviewed journals. Conducted integrative multi-omics analyses characterizing transcriptional regulatory networks in tissue regeneration. Authored 4 first-author publications.
Designed and deployed CompleteMOTIFs, a scalable web-based bioinformatics platform for transcription factor binding analysis adopted by 100+ Harvard researchers.